JBI Database System Rev Implement Rep
October 2018
Introduction: Counseling is a brief psycho-educational intervention that is useful in facilitating personal growth and adaptive resolution of life stresses. With increased recognition on the psycho-emotional needs of patients with cancer, it is prudent to consider the possibility of expanding the role of nurses in the provision of counseling.
Objective: This qualitative systematic review aimed to establish the best available evidence on the experiences of adult cancer patients receiving counseling provided by nurses.
JBI Database System Rev Implement Rep
July 2016
The aim of this review is to establish the best available evidence on the experiences of adult patients with cancer receiving counseling provided by nurses in the institutional and community setting.
View Article and Find Full Text PDFJBI Database System Rev Implement Rep
July 2016
The objective of this review is to review and synthesize evidence on the effectiveness of polyhexamethylene biguanide (PHMB) impregnated dressing in wound treatment for patients with chronic or acute wounds, compared with standard dressings or any other antimicrobial dressings.Specifically the questions for this review are.
View Article and Find Full Text PDFJBI Database System Rev Implement Rep
August 2015
Background: Patients' satisfaction with hospital services is an important indicator in demonstrating that nursing care meets their expectations. Hospitals are responsible for providing safe and quality care to patients during their hospitalization and ensuring patients receive continued care post‑discharge. Interventions such as nurse leader rounding and post-discharge telephone calls could potentially enhance patients' hospital stay, meeting their expectations and needs in a timely manner.
View Article and Find Full Text PDFRapid rituximab infusion was approved as treatment for non-Hodgkin lymphoma by the U.S. Food and Drug Administration in 2012, but it has been administered clinically since approval of the drug rituximab in 1997.
View Article and Find Full Text PDFPurpose: This study aimed to identify the predictors of acute adverse events resulting from rapid rituximab infusion over 90 min.
Method: It was a retrospective cohort study using medical record review based on a convenience sampling from 2007 till May 2011 in both in-patient and ambulatory setting in Royal Adelaide Hospital.
Results: There were a total of 294 patients who received 376 courses and 1,571 cycles of rapid rituximab infusion.
Background And Objectives: Non-invasive methods based on applanation tonometry have been proposed to estimate central blood pressure. However, the accuracy of these methods hasn't been systematically examined.
Methods: We performed a systematic review and meta-analysis of studies comparing estimated and invasively measured central BP.
Asia Pac J Clin Oncol
March 2012
Aim: To assess safety of rapid infusion by measuring infusion-related side effects and toxicities.
Methods: Participants received the first rituximab infusion according to the manufacturers' recommendations. If well-tolerated, they then received the second and subsequent infusions at a rate of 20% of the dose over the first 30 min and the remaining 80% over the next hour.
Background: Increasing numbers of studies identify new prognostic factors for categorising chemotherapy-induced febrile neutropenia adult cancer patients into high- or low-risk groups for adverse outcomes. These groupings are used to tailor therapy according to level of risk. However many emerging factors with prognostic significance remain controversial, being based on single studies only.
View Article and Find Full Text PDFJpn J Nurs Sci
December 2011
Objective: The objective of this review was to critically analyze and systematically review the best evidence related to the effectiveness of the Sitz bath in managing adult patients with anorectal disorders.
Methods: The text terms were established and searched systematically from the relevant databases from 1990 to November 2009 in the English language. The eligible studies that were congruent with the review's inclusion criteria were selected.
Int J Nurs Pract
August 2011
The purpose of this study is to critically appraise, synthesize and present the best available evidence related to the safety of rapid rituximab infusion in adult non-Hodgkin lymphoma and chronic lymphocytic leukaemia patients. Data are from published and unpublished studies from electronic databases, grey literature and reference lists. The studies that met the inclusion criteria were critically appraised by two independent reviewers for methodological validity using standardized critical appraisal instruments.
View Article and Find Full Text PDFBackground: Protective isolation is one of the precautionary measures put in place for neutropenic cancer patients, where patients will be placed in an isolation room during their medical treatment in the hospital. The purpose of this practice is to minimise neutropenic patients from contracting nosocomial infection and the length of stay in the isolation room varies depending on their medical condition. It has been reported in some literature that this group of patients experience social isolation, a wide range of emotions and psychological burdens such as depression and anxiety as a result of staying in the isolation room.
View Article and Find Full Text PDFBackground: Blood pressures determined at different sites vary considerably. Non-invasive methods are available to estimate central aortic blood pressure, the blood pressure at the origin of all arterial pulses. These methods obtain estimated central blood pressure by calibration and/or mathematical calculations for peripheral pulse waveforms.
View Article and Find Full Text PDFBackground: Rapid Rituximab infusion has become increasingly popular globally. Although pharmaceutical manufacturers recommend second and subsequent infusions to run over 2-3 hours, many cancer centres have changed their clinical practice based on their own research and the results from other primary studies. Such research studies claim that it is safe to administer Rituximab rapidly among cancer patients especially in Non Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL).
View Article and Find Full Text PDF